Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing
NCT02304510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2455
Last updated 2018-12-31
Summary
The purpose of the study is to estimate the prevalence of heavy menstrual bleeding (HMB) in females aged between 18 and 50 years old living in Bejing.
Conditions
- Menorrhagia
Sponsors & Collaborators
- collaborator INDUSTRY
-
Peking University
lead OTHER
Principal Investigators
-
Siyan Zhan, MD,PhD · Peking University Health Science Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2015-09-30
- Completion
- 2016-12-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
NCT02443233 ·Status: COMPLETED
-
Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica
NCT00339807 ·Status: COMPLETED
-
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection
NCT02511743 ·Status: COMPLETED
-
Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family History
NCT04672915 ·Status: UNKNOWN
-
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
NCT01765231 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
NCT02112890 ·Status: COMPLETED
-
Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients
NCT05991531 ·Status: UNKNOWN
-
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 ·Status: COMPLETED ·Phase: PHASE4
-
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952 ·Status: RECRUITING
-
Dose of Hepatitis B Vaccines in Non/Low-response Populations
NCT01564134 ·Status: COMPLETED ·Phase: NA
-
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
NCT03108794 ·Status: RECRUITING
-
Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children
NCT04439435 ·Status: UNKNOWN
-
Population-wide Research for HBV-related Liver Diseases in Maoming City
NCT06184347 ·Status: NOT_YET_RECRUITING
-
Prevalence of Hepatitis B Infection in the Galilee Region, Israel
NCT01645007 ·Status: WITHDRAWN
-
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
NCT00702663 ·Status: UNKNOWN
-
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment
NCT02336399 ·Status: UNKNOWN
-
Response Prediction in EBV-HLH Using Metabonomics Analysis
NCT05677178 ·Status: UNKNOWN
-
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
NCT04032392 ·Status: UNKNOWN ·Phase: PHASE1
-
A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in China
NCT04538651 ·Status: UNKNOWN
-
B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
NCT00465582 ·Status: TERMINATED
-
Qidong Hepatitis B Intervention Study
NCT00222664 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus
NCT03932851 ·Status: UNKNOWN
-
REALM China Extension Study
NCT02974829 ·Status: UNKNOWN
-
Epidemiological Survey of Hepatitis D Virus Infection in China
NCT04483518 ·Status: COMPLETED
-
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study
NCT01502397 ·Status: COMPLETED